<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:g-custom="http://base.google.com/cns/1.0" version="2.0">
  <channel>
    <title>persimmon</title>
    <link>https://www.persimmon.engineering</link>
    <description />
    <atom:link href="https://www.persimmon.engineering/feed/rss2" type="application/rss+xml" rel="self" />
    <image>
      <title />
      <url>https://irp.cdn-website.com/65db9ce1/dms3rep/multi/PE-Logo-Rever.png</url>
      <link>https://www.persimmon.engineering</link>
    </image>
    <item>
      <title>GDP Responsible Person Requirements</title>
      <link>https://www.persimmon.engineering/gdp-responsible-person-requirements</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;h3&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Master the regulatory framework, essential qualifications, and organizational duties for a Good Distribution Practice (GDP) Responsible Person.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/h3&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Primary Keywords
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            GDP Responsible Person, Good Distribution Practice, GDP Requirements, Quality Management, Pharma Compliance
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Targeted Phrases
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Duties of a GDP responsible person, EU GDP Guidelines 2013/C 343/01, pharmaceutical wholesale distribution compliance, GDP training and QMS implementation, role of RP in medicinal product logistics
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Hashtags
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            #GDP #PharmaCompliance #QualityManagement #RegulatoryAffairs #PersimmonEngineering
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <pubDate>Fri, 10 Apr 2026 08:31:36 GMT</pubDate>
      <guid>https://www.persimmon.engineering/gdp-responsible-person-requirements</guid>
      <g-custom:tags type="string" />
    </item>
    <item>
      <title>Good Distribution Practice (GDP) Essentials</title>
      <link>https://www.persimmon.engineering/good-distribution-practice-gdp-essentials</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;h3&gt;&#xD;
    &lt;span&gt;&#xD;
      
           A comprehensive guide to maintaining pharmaceutical supply chain integrity, regulatory compliance, and robust quality management systems.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/h3&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Primary Keywords:
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Good Distribution Practice, GDP compliance, pharmaceutical logistics, supply chain integrity
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Targeted Phrases:
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            EU GDP Guidelines for human medicinal products, pharmaceutical quality management system requirements, cold chain management for medicinal products, handling pharmaceutical product recalls
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Hashtags:
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            #PharmaLogistics #GDPCompliance #SupplyChainSafety #DrugSafety #QualityManagement
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <pubDate>Fri, 10 Apr 2026 08:28:33 GMT</pubDate>
      <guid>https://www.persimmon.engineering/good-distribution-practice-gdp-essentials</guid>
      <g-custom:tags type="string" />
    </item>
    <item>
      <title>GMP Compliance for Biologics</title>
      <link>https://www.persimmon.engineering/gmp-compliance-for-biologics</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;h3&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Navigate European and international GMP regulations for biotechnological products, focusing on process control, virus safety, and inherent variability. 
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/h3&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Primary Keywords (Short-Tail)
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            GMP Compliance, Biologics, Pharma Regulations, Quality Control, EU GMP. 
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Targeted Phrases (Long-Tail)
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            GMP requirements for biotechnological products, EU GMP Annex 2 compliance, ICH Q5A virus safety standards, biological process validation, critical process parameters in pharma.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Hashtags
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            #Biologics #GMPCompliance #PharmaTech #RegulatoryAffairs #QualityControl 
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <pubDate>Fri, 10 Apr 2026 08:25:20 GMT</pubDate>
      <guid>https://www.persimmon.engineering/gmp-compliance-for-biologics</guid>
      <g-custom:tags type="string" />
    </item>
    <item>
      <title>Rouging in Pharma Water &amp; Steam Systems: Causes &amp; Control</title>
      <link>https://www.persimmon.engineering/rouging-in-pharma-water-steam-systems-causes-control</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;h3&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Explore the mechanisms of stainless steel oxidation, rouging classifications, and actionable lifecycle management strategies to ensure GMP compliance in your pharmaceutical facility.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/h3&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Primary Keywords:
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Rouging, Pharmaceutical Water Systems, Pure Steam Systems, Derouging, Passivation.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Targeted Phrases
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : Causes of rouging in stainless steel, how to control rouging in WFI systems, thermal sanitisation effects on rouging, Class I II III rouging classification.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Hashtags
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      
           : #PharmaEngineering #WaterSystems #Rouging #GMPCompliance #SystemValidation #PersimmonEngineering.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <pubDate>Fri, 10 Apr 2026 08:21:06 GMT</pubDate>
      <guid>https://www.persimmon.engineering/rouging-in-pharma-water-steam-systems-causes-control</guid>
      <g-custom:tags type="string" />
    </item>
    <item>
      <title>EMA GMP Guidelines Update 2026-2028</title>
      <link>https://www.persimmon.engineering/ema-gmp-guidelines-update-2026-2028</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;h3&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Prepare for the EMA's new 3-year work plan including updates to Annex 15, Annex 22, and key GMP chapters.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/h3&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Primary Keywords: EMA GMP Guidelines, GMDP IWG, Annex 15 Validation, Annex 22 AI
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Targeted Phrases: EMA 3-year work plan for GMP inspectors, revision of GMP requirements 2026, Annex 22 Artificial Intelligence guidelines
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Hashtags: #EMAGMP #RegulatoryCompliance #PharmaValidation #Annex15 #Annex22
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <pubDate>Fri, 10 Apr 2026 08:17:36 GMT</pubDate>
      <guid>https://www.persimmon.engineering/ema-gmp-guidelines-update-2026-2028</guid>
      <g-custom:tags type="string" />
    </item>
    <item>
      <title>FDA Warning Letter: Aseptic Manufacturing Deficiencies</title>
      <link>https://www.persimmon.engineering/fda-warning-letter-aseptic-manufacturing-deficiencies</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;h3&gt;&#xD;
    &lt;span&gt;&#xD;
      
           An in-depth analysis of Simtra BioPharma's CGMP violations, highlighting risks from equipment dead legs, failed CAPA, and systemic contamination.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/h3&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Primary Keywords
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            FDA Warning Letter, Aseptic Manufacturing, CGMP Compliance, CAPA, Simtra BioPharma
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Targeted Phrases
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            resolving FDA Form 483 observations, correcting dead legs in pharmaceutical piping, preventing sterile manufacturing contamination, implementing effective CAPA in pharma, unannounced FDA inspections in Europe
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Hashtags
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            #PharmaCompliance #FDAWarningLetter #AsepticManufacturing #CGMP #QualityAssurance #PersimmonEngineering #CAPA
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <pubDate>Fri, 10 Apr 2026 08:10:45 GMT</pubDate>
      <guid>https://www.persimmon.engineering/fda-warning-letter-aseptic-manufacturing-deficiencies</guid>
      <g-custom:tags type="string" />
    </item>
    <item>
      <title>FDA Warning: CAPA &amp; Root Cause Failures</title>
      <link>https://www.persimmon.engineering/fda-warning-capa-root-cause-failures</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;h3&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Discover key GMP violations from the recent FDA Warning Letter to OraLabs Inc. Learn why rigorous Root Cause Analysis is critical for compliance.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/h3&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Primary Keywords
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            FDA Warning Letter, CAPA Process, Root Cause Analysis, GMP Violation, 21 CFR 211.192.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Targeted Phrases
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            inadequate root cause analysis in pharma, FDA inspection CAPA actions, microbiological deviation investigations, CFR 211.192 compliance, pharmaceutical lot release risks.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Hashtags
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            #FDACompliance #GMP #CAPA #RootCauseAnalysis #PharmaManufacturing #RegulatoryAffairs #PersimmonEngineering
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <pubDate>Fri, 10 Apr 2026 07:59:37 GMT</pubDate>
      <guid>https://www.persimmon.engineering/fda-warning-capa-root-cause-failures</guid>
      <g-custom:tags type="string" />
    </item>
    <item>
      <title>FDA Warning: Severe Data Integrity Failures</title>
      <link>https://www.persimmon.engineering/fda-warning-severe-data-integrity-failures</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;h3&gt;&#xD;
    &lt;span&gt;&#xD;
      
           An Indian lab faces FDA action for systemic data destruction, backdated records, and inspection obstruction. See how this impacts CGMP compliance.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/h3&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Primary Keywords:
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            FDA Warning Letter, Data Integrity, CGMP Compliance, Pharma Quality Assurance, OOS Results, Data Governance, Lab Validation
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Targeted Phrases (Long-Tail):
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            FDA data integrity violations, Contract testing laboratory warning letter, CGMP documentation practices, Out-of-specification (OOS) investigations, Falsified analytical records FDA, Pharmaceutical CAPA tracking, Persimmon Engineering compliance audit
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Hashtags:
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            #FDACompliance #DataIntegrity #CGMP #PharmaTech #QualityAssurance #RegulatoryAffairs #PersimmonEngineering #DataGovernance
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <pubDate>Fri, 10 Apr 2026 07:49:44 GMT</pubDate>
      <guid>https://www.persimmon.engineering/fda-warning-severe-data-integrity-failures</guid>
      <g-custom:tags type="string" />
    </item>
    <item>
      <title>Patient-Centric ATMP Specifications</title>
      <link>https://www.persimmon.engineering/patient-centric-atmp-specifications</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;h3&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Navigate the regulatory shift towards patient-centric quality attributes for autologous cell and gene therapies with expert insights.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/h3&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Primary Keywords (Short-Tail)
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            ATMP, Cell Therapy, Gene Therapy, Regulatory Compliance, ICH Guidelines, Patient-Centric.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Targeted Phrases (Long-Tail)
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Patient-centric specifications for ATMPs, Autologous cell therapy regulatory guidelines, Overcoming out-of-specification in cell therapies, ECA ATMP Group position paper summary, Pharmaceutical validation for advanced therapies.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Hashtags
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            #ATMP #CellTherapy #RegulatoryCompliance #PatientCentricity #PharmaTech #PersimmonEngineering #Validation
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <pubDate>Fri, 10 Apr 2026 07:36:14 GMT</pubDate>
      <guid>https://www.persimmon.engineering/patient-centric-atmp-specifications</guid>
      <g-custom:tags type="string" />
    </item>
    <item>
      <title>FDA Warning: Equipment Design &amp; Biofilm Risks</title>
      <link>https://www.persimmon.engineering/fda-warning-letter-equipment-design-issues</link>
      <description />
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;h3&gt;&#xD;
    &lt;span&gt;&#xD;
      
           How ignored Performance Qualification (PQ) failures and systemic dead legs in pharmaceutical water systems led to an FDA Warning Letter.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/h3&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Primary Keywords (Short-Tail):
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            FDA Warning Letter, Hygienic Design, Water Systems, Biofilm, Equipment Qualification.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Targeted Phrases (Long-Tail):
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            Dead legs in pharmaceutical water systems, Performance Qualification (PQ) failures, FDA cGMP equipment design compliance, Resolving stagnant piping locations, Waterborne microbiological contamination.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;strong&gt;&#xD;
      
           Hashtags:
          &#xD;
    &lt;/strong&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;span&gt;&#xD;
        
            #PharmaCompliance #FDAWarningLetter #HygienicDesign #Validation #PersimmonEngineering.
           &#xD;
      &lt;/span&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <pubDate>Fri, 10 Apr 2026 07:31:34 GMT</pubDate>
      <guid>https://www.persimmon.engineering/fda-warning-letter-equipment-design-issues</guid>
      <g-custom:tags type="string" />
    </item>
  </channel>
</rss>
